|
 Laboratory
Tests: Sickle
Cell Screening
 Sickle cell
disease affects children primarily of African, Mediterranean,
or Caribbean heritage, but other ethnic groups can be at risk.
Approximately 1 in 400 children of African heritage are affected.
All infants
and children at risk for sickle cell disease must be screened,
with test results documented in the medical record. If previous
test results are not documented, rescreen if the child is at
risk. If the child is not at risk (through ethnicity or documented
test results), note this in the record.
All newborns in the District of Columbia should
be screened for sickle cell disease through DC’s Newborn Screening
Program.
Screening
Follow-up
- Screen all
newborns for sickle cell disease as part of DC's
Newborn Screening Program.
- Screen children
at risk for sickle cell disease if test results are not documented
in child's medical record.
- Document
results of all follow-up hemoglobinopathy screening in the medical
record.
- If child
is not at risk (by ethnicity or previous screening), indicate
this in medical record.
|
